Susi Roger E. 4

What Happened
Roger E. Susi, a reported 10% owner of IRADIMED Corp (IRMD), sold a total of 7,500 shares in open-market transactions on March 23–24, 2026, generating approximately $752,610 in proceeds. The sales break down as: 2,950 shares at a weighted average $99.58 ($293,761), 750 shares at $100.70 ($75,525), 1,300 shares at $102.02 ($132,626), 1,585 shares at $100.03 ($158,548), and 915 shares at $100.71 ($92,150). All transactions are reported as sales (S), so this is a disposition, not a purchase.

Key Details

• Transaction dates: March 23–24, 2026; Form 4 filed March 25, 2026 (timely filing).
• Total shares sold: 7,500; total proceeds: ~$752,610.
• Individual trades (weighted avg prices / proceeds):
  • 3/23: 2,950 @ $99.58 = $293,761 (prices ranged $99.02–$100.00)
  • 3/23: 750 @ $100.70 = $75,525 (prices ranged $100.05–$100.97)
  • 3/23: 1,300 @ $102.02 = $132,626 (prices ranged $102.00–$102.08)
  • 3/24: 1,585 @ $100.03 = $158,548 (prices ranged $99.49–$100.40)
  • 3/24: 915 @ $100.71 = $92,150 (prices ranged $100.53–$100.97)
• Footnotes: Sales were effected under a Rule 10b5-1 trading plan adopted Nov 5, 2025 (F1). Multiple trades produced the reported weighted-average prices; the filer will provide trade-level details on request (F2–F6). The filer disclaims beneficial ownership except to the extent of pecuniary interest (F7).
• Filing timeliness: Transactions occurred 3/23–3/24 and the Form 4 was filed 3/25 — no late-filing indication.

Context: Susi is a 10% owner (large shareholder) rather than an executive; sales under an established 10b5-1 plan are typically pre-planned dispositions and do not necessarily signal a change in view about the company. This report documents dispositions only — no purchases, exercises, or awards were reported.